References
- Benet L. Z., Sheiner L. B. Design and optimization of dosage regimens; pharmacokinetic data. The Pharmacological Basis of Therapeutics 7th edn, A. G. Gilman, L.S. Goodman, T. W. Rall, F. Murad. Macmillan, New York 1985; 1663–1733
- Chatelain P., Laruel R. Amiodarone partitioning with phospholipid bilayers and erythrocyte membranes. Journal of Pharmaceutical Sciences 1985; 74: 783–743
- D'Amico D. J., Kenyon K. R., Ruskin J. N. Amiodarone keratopathy. Archives of Ophthalmology 1981; 99: 257–261
- De Duve C., De Barsy T., Poole B., Trouet A., Tulkens P., Van Hoof F. Lysosomotropic agents. Biochemical Pharmacology 1974; 23: 2495–2531
- Gupta D. K., Gieselmann V., Hasilik A., Von Figura K. Tilorone acts as a lysosomotropic agent in fibroblasts. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 1984; 365: 859–866
- Handrock K., Hein L., Lüllmann-Rauch R. Drug-induced mucopolysaccharidosis (MPS): cytological and physicochemical investigations. Naunyn-Schmiedeberg's Archives of Pharmacology 1989; 339: R31, (abstract)
- Hein L, Lüllmann-Rauch R. Mucopolysaccharidosis and lipidosis in rats treated with tilorone analogues. Toxicology 1989; 58: 145–154
- Lazarus S. S., Vethamany V. G., Schneck L., Volk B. W. Fine structure and histochemistry of peripheral blood cells in Niemann-Pick disease. Laboratory Investigations 1967; 17: 155–170
- Lüllmann H., Mohr K. Drug phospholipid interactions,. Metabolism of Xenobiotics, J. W. Gorrod, H. Oelschläger, J. Caldwell. Taylor & Francis, London 1988; 13–20
- Lüllmann H., Lüllmann-Rauch R., Wassermann O. Drug-induced phospholipidosis. Critical Reviews in Toxicology 1975; 4: 185–218
- Lüllmann H., Plösch H., Ziegler A. Ca2+ -replacement by cationic amphiphilic drugs from lipid monolayers. Biochemical Pharmacology 1980; 29: 2969–2974
- Lüllmann H., Rossen E., Seiler K. U. The pharmacokinetics of phentermine and chlorphentermine in chronically treated rats. Journal of Pharmacy and Pharmacology 1973; 25: 239–243
- Lüllmann-Rauch R. Chlorphentermine-induced abnormal cytoplasmic inclusions in peripheral blood cells of rats and guinea pigs. Toxicology and Applied Pharmacology 1975; 32: 32–39
- Lüllman-Rauch R. Drug-induced lysosomal storage disorders. Lysosomes in Applied Biology and Therapeutics, J. T. Dingle, P. J. Jacques, I. H. Shaw. North-Holland, Amsterdam 1979; 49–130
- Lüllmann-Rauch R. Tilorone-induced lysosomal storage mimicking the features of mucopolysaccharidosis and of lipidosis in rat liver. Virchows Archiv. B, Cell Pathology 1983; 44: 355–368
- MacIntyre A. C., Cutler D. J. The potential role of lysosomes in tissue distribution of weak bases. Biopharmaceutics and Drug Disposition 1988; 9: 513–526
- Martin W. J., II, Standing J. E. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects. Journal of Pharmacology and Experimental Therapeutics 1988; 244: 774–779
- Martindale. The Extra Pharmacopoeia 29th edn, J. E. F. Reynolds. Pharmaceutical Press, London 1989; xxiv, 71
- Mason J. W. Amiodarone. New England Journal of Medicine 1987; 316: 455–466
- Ohkuma S., Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proceedings of the National Academy of Sciences, USA 1978; 75: 3327–3331
- Poucell S., Ireton J., Valencia-Mayoral P., Downar E., Larratt L., Patterson J., Blendis L., Phillips M. J. Amiodarone-associated phospholipidosis and fibrosis of the liver. Gastroenterology 1984; 86: 926–936
- Prokopek M. Drug-induced mucopolysaccharidosis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 1989; 339: R32, (abstract)
- Reeves J. P. The mechanism of lysosomal acidification. Lysosomes in Biology and Pathology, J. T. Dingle, R. T. Dean, W. Sly. Elsevier, Amsterdam 1984; Vol. 7: 175–199
- Regelson W. The biological activity of the synthetic polyanion, pyran copolymer (Diveema, MVE, 46015) and the heterocyclic bis DEAE fluorenone derivative, tilorone and congeners: clinical and laboratory effects of these agents as modulators of host resistance. Pharmacology and Therapeutics 1981; 15: 1–44
- Rudnick G. ATP-driven H+ pumping into intracellular organelles. Annual Reviews of Physiology 1986; 48: 404–413
- Yamamoto A., Adachi S., Ishikawa K., Yokomura T., Kitani T., Nasu T., Imoto T., Nishikawa M. Studies on drug-induced lipidosis. III. Lipid composition of the liver and some other tissues in clinical cases of ‘Niemann-Pick-like syndrome’ induced by 4,4′-diethyl-aminoethoxyhexestrol. Journal of Biochemistry 1971; up: 775–784
- Zbinden G., Emch E. Effect of tilorone HCl, an oral inteferon-inducer, on leukopoiesis in rats. Acta Haematologica 1972; 47: 49–58